Sally Ibrahim Hassanein

Sally Ibrahim Hassanein

Auto-generated profile, based on publicly available information

Sally Ibrahim Hassanein


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2016 in Nutritional Neuroscience
Verified
Journal Article
Closed access
SASahar M. Abdel-Maksoud
Sahar M. Abdel-Maksoud
SHSally I. Hassanein
Sally I. Hassanein
NGNeveen A. Gohar
Neveen A. Gohar
SASaad M. M. Attia
Saad M. M. Attia
Mohamed Zakaria GadMohamed Zakaria Gad
Mohamed Zakaria Gad
Purpose: The aim of this study was investigating the effect of omega-3 fatty acids (ω-3 FAs) on brain-derived neurotrophic factor (BDNF) gene expression, using in vivo and in vitro models, to unravel the potential mechanisms of polyunsaturated fatty acids use in obesity. Materials and methods: Twenty-nine Sprague-Dawley rats were divided into three groups; lean controls fed normal chow diet for 14 weeks, obese controls fed 60% of their diet as saturated fats for 14 weeks, and ω-3 FAs-treated rats fed 60% saturated fat diet for 14 weeks with concomitant oral administration of 400 mg/kg/day ω-3 FAs, mainly docosahexaenoic acid and EPA, from week 12 to week 14. For the in vitro experiment, hypothalamic cells from six obese rats were cultured in the presence of different concentrations of ω-3 FAs to determine its direct effect on BDNF expression. Results: In vivo results showed that obesity has negative effect on BDNF gene expression in rat hypothalamus that was reversed by administration of ω-3 FAs. Obese rats showed hypercholesterolemia, hypertriglyceridemia, normoinsulinemia, hyperglycemia and hyperleptinemia. Treatment with ω-3 FAs showed significant decrease in serum total cholesterol and TAG. Also serum glucose level and HOMA index were decreased significantly. In vitro results demonstrated the increase in BDNF expression by ω-3 FAs in a dose-dependent manner. Conclusions: Obesity causes down-regulation of BDNF gene expression that can be reversed by ω-3 FAs treatment, making them an interesting treatment approach for obesity and metabolic disease.

3 September 2014 in Journal of Receptors and Signal Transduction
Verified
Journal Article
Closed access
PDF file
MMMohamed Abu el Maaty
Mohamed Abu el Maaty
SASally I. Sally I. Hassanein Biochemistry Department, Faculty of Pharmacy and Biotechnology, German University in Cairo (GUC), Cairo, Egypt and
Sally I. Sally I. Hassanein Biochemistry Department, Faculty of Pharmacy and Biotechnology, German University in Cairo (GUC), Cairo, Egypt and
Context/objective: Previous studies have illustrated the association of the ApaI and TaqI polymorphisms of the vitamin D receptor gene, located in non-coding and coding regions, respectively, with diseases such as cancer and cardiovascular disease; however, investigating such association in Egyptian patients with coronary artery disease (CAD) has never been formerly attempted. Materials and methods: Male patients (n = 137), 35–50 years of age, with verified CAD, were recruited alongside age- and sex-matched controls (n = 58). Genotyping and 25-hydroxyvitamin D [25(OH)D] measurement were performed by polymerase chain reaction RFLP and HPLC, respectively. Results: Comparison of the genotypic distribution of both the TaqI and ApaI polymorphisms between patients and controls yielded insignificant results (p = 0.55 and 0.7, respectively). Comparison of the allelic distribution of both polymorphisms also yielded insignificant results. The TaqI polymorphism was not found to predict 25(OH)D levels, whereas the wild-type genotype of the ApaI polymorphism was associated with greater levels of 25(OH)D (p = 0.02), taking all subjects into consideration. Discussion/conclusion: This study presents the ApaI and TaqI polymorphisms as non-influencing players in the pathogenesis of CAD in Egyptian males and the ability of only the ApaI polymorphism to predict 25(OH)D levels, thus warranting further investigations of the triangular relationship between the polymorphisms, 25(OH)D and CAD incidence.

3 October 2018 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MAMina Amir
Mina Amir
SHSally I. Hassanein
Sally I. Hassanein
MRMohamed F. Abdel Rahman
Mohamed F. Abdel Rahman
MGMohamed Z. Gad
Mohamed Z. Gad

23 January 2025 in Journal of Engineering and Science in Medical Diagnostics and Therapy
Verified
Journal Article
Open access
PDF file
SAShereen Moataz Afifi
Shereen Moataz Afifi
MFM. Hamdy Faragallah
M. Hamdy Faragallah
RTRadwa Taha
Radwa Taha
MBMirza Mansoor Baig
Mirza Mansoor Baig
Ehsan UllahEhsan Ullah
Ehsan Ullah
SHSally I. Hassanein
Sally I. Hassanein
This review investigates the effectiveness of exploiting the massive Artificial Intelligence (AI) technology in the diagnosis of prostate cancer histopathological images. It focuses on studying and analyzing the current state and practice for utilizing AI tools, including significant machine learning and deep learning models in the histopathological image analysis process. The preferred reporting items for systematic reviews and meta-analyses (PRISMA) methodology was adopted for conducting this systematic review to include recent research articles that have been published since 2017. Leveraging novel deep learning models and advanced imaging techniques, AI demonstrates promising capabilities in improving accuracy and efficiency in detecting and classifying prostate cancer. A comprehensive comparison of existing works has been presented with in-depth discussions around current limitations and key challenges while proposing some future advancements. This study aims to pave the way for future research and further integration of AI into the diagnostic processes toward early detection, personalized treatment strategies, and enhanced patient outcomes in the context of a prostate cancer diagnosis.

17 March 2021 in Steroids
Verified
Journal Article
Closed access
MEMariam M. Elbehairy
Mariam M. Elbehairy
HAHala Y. Abdelnasser
Hala Y. Abdelnasser
Rasha Sayed HanafiRasha Sayed Hanafi
Rasha Sayed Hanafi
SHSally I. Hassanein
Sally I. Hassanein
Mohamed Zakaria GadMohamed Zakaria Gad
Mohamed Zakaria Gad

12 June 2023 in Research Square
Verified
Preprint
Open access
PDF file
SISally Ibrahim
Sally Ibrahim
DODina Osama
Dina Osama
AHAhmed Hegazy
Ahmed Hegazy
HHHafiz Hashmi
Hafiz Hashmi
KAKhaled Abou-Aisha
Khaled Abou-Aisha
MGMohammed.Z Gad
Mohammed.Z Gad
Background: Myocardial microRNAs (Myo-miR) like MiR-1, miR-133 and miR-208 are specific to cardiac muscles development and function. Diagnostic potential of MiR-1, miR-133 and miR-208 in acute episodes of myocardial infarction is unknown. Methods: Patient of newly onset of acute myocardial infarction with elevated ST-segment admitted to Ain-Shams university hospital Cairo from May 2013 to December 2022 were enrolled. Written consent was obtained. Circulating MiRNAs were measured at 04, 08, 12, 24, 48 hours from onset of angina by RT-PCR and compare with conventional creatin-kinases for diagnostic potential. Results were analyzed by student t-test, ROC curve calculations and ANOVA were performed using GraphPad-Prism-9Version. Results: 746 patients admitted with STEMI and 10(1.34%) cases were presented with new-onset episodes of STEMI with mean±SD age 54.2±8.49 year. miR-133a peaks at 8 hours, miR-208b peaks at 12 hours from onset of AMI compared to cTnI and CK-MB peak at 12hrs(P<0.001). ROC-curve for miR-133a AUC was 0.583,0.8,1,0.78 and 0.58 at 4,8,12,24 & 48 hours respectively. AUC for miR-208b was 0.87,0.888,0.888,0.627 compared to AUC of cTnI concentrations 0.59,1,1,0.75,0 and (ROC) curve for CK-MB was 0.59,1,1,0.8&0.73 respectively. Positive correlation was present between miR-133a and cTnI (R=0.926-R2= 0.858 P=0.47), miR-208b and cTnI (R=0.8-R2=0.64 P=0.1) , miR-208b and CK-MB was (R=0.888-R2=0.789 P=0.044) and CK-MB-cTnI (R=0.72) respectively. Conclusion: We showed miR-133a and miR-208b diagnostic specificity superior over conventional blood biomarkers for acute onset of STEMI. (NCT05692752)